BioCorRx Inc. (BICX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $797.2K | +10301.1% |
| 2024 | $7.7K | -91.4% |
| 2023 | $89.2K | -58.3% |
| 2022 | $213.8K | +343.0% |
| 2021 | $48.3K | -60.6% |
| 2020 | $122.6K | -49.0% |
| 2019 | $240.3K | -36.2% |
| 2018 | $376.7K | -42.7% |
| 2017 | $657.3K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $797.2K | +10301.1% |
| 2024 | $7.7K | -91.4% |
| 2023 | $89.2K | -58.3% |
| 2022 | $213.8K | +343.0% |
| 2021 | $48.3K | -60.6% |
| 2020 | $122.6K | -49.0% |
| 2019 | $240.3K | -36.2% |
| 2018 | $376.7K | -42.7% |
| 2017 | $657.3K | — |